Guidelines for reporting pediatric and child health clinical trial protocols and reports: study protocol for SPIRIT-Children and CONSORT-Children.
CONSORT
Child health
Clinical trial
Patient and public involvement
Pediatrics
Reporting guideline
SPIRIT
Trial protocol
Trial report
Young people
youth involvement
Journal
Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253
Informations de publication
Date de publication:
30 Jan 2024
30 Jan 2024
Historique:
received:
06
09
2023
accepted:
22
01
2024
medline:
30
1
2024
pubmed:
30
1
2024
entrez:
30
1
2024
Statut:
epublish
Résumé
Despite the critical importance of clinical trials to provide evidence about the effects of intervention for children and youth, a paucity of published high-quality pediatric clinical trials persists. Sub-optimal reporting of key trial elements necessary to critically appraise and synthesize findings is prevalent. To harmonize and provide guidance for reporting in pediatric controlled clinical trial protocols and reports, reporting guideline extensions to the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) and Consolidated Standards of Reporting Trials (CONSORT) guidelines specific to pediatrics are being developed: SPIRIT-Children (SPIRIT-C) and CONSORT-Children (CONSORT-C). The development of SPIRIT-C/CONSORT-C will be informed by the Enhancing the Quality and Transparency of Health Research Quality (EQUATOR) method for reporting guideline development in the following stages: (1) generation of a preliminary list of candidate items, informed by (a) items developed during initial development efforts and child relevant items from recent published SPIRIT and CONSORT extensions; (b) two systematic reviews and environmental scan of the literature; (c) workshops with young people; (2) an international Delphi study, where a wide range of panelists will vote on the inclusion or exclusion of candidate items on a nine-point Likert scale; (3) a consensus meeting to discuss items that have not reached consensus in the Delphi study and to "lock" the checklist items; (4) pilot testing of items and definitions to ensure that they are understandable, useful, and applicable; and (5) a final project meeting to discuss each item in the context of pilot test results. Key partners, including young people (ages 12-24 years) and family caregivers (e.g., parents) with lived experiences with pediatric clinical trials, and individuals with expertise and involvement in pediatric trials will be involved throughout the project. SPIRIT-C/CONSORT-C will be disseminated through publications, academic conferences, and endorsement by pediatric journals and relevant research networks and organizations. SPIRIT/CONSORT-C may serve as resources to facilitate comprehensive reporting needed to understand pediatric clinical trial protocols and reports, which may improve transparency within pediatric clinical trials and reduce research waste. The development of these reporting guidelines is registered with the EQUATOR Network: SPIRIT-Children ( https://www.equator-network.org/library/reporting-guidelines-under-development/reporting-guidelines-under-development-for-clinical-trials-protocols/#35 ) and CONSORT-Children ( https://www.equator-network.org/library/reporting-guidelines-under-development/reporting-guidelines-under-development-for-clinical-trials/#CHILD ).
Sections du résumé
BACKGROUND
BACKGROUND
Despite the critical importance of clinical trials to provide evidence about the effects of intervention for children and youth, a paucity of published high-quality pediatric clinical trials persists. Sub-optimal reporting of key trial elements necessary to critically appraise and synthesize findings is prevalent. To harmonize and provide guidance for reporting in pediatric controlled clinical trial protocols and reports, reporting guideline extensions to the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) and Consolidated Standards of Reporting Trials (CONSORT) guidelines specific to pediatrics are being developed: SPIRIT-Children (SPIRIT-C) and CONSORT-Children (CONSORT-C).
METHODS
METHODS
The development of SPIRIT-C/CONSORT-C will be informed by the Enhancing the Quality and Transparency of Health Research Quality (EQUATOR) method for reporting guideline development in the following stages: (1) generation of a preliminary list of candidate items, informed by (a) items developed during initial development efforts and child relevant items from recent published SPIRIT and CONSORT extensions; (b) two systematic reviews and environmental scan of the literature; (c) workshops with young people; (2) an international Delphi study, where a wide range of panelists will vote on the inclusion or exclusion of candidate items on a nine-point Likert scale; (3) a consensus meeting to discuss items that have not reached consensus in the Delphi study and to "lock" the checklist items; (4) pilot testing of items and definitions to ensure that they are understandable, useful, and applicable; and (5) a final project meeting to discuss each item in the context of pilot test results. Key partners, including young people (ages 12-24 years) and family caregivers (e.g., parents) with lived experiences with pediatric clinical trials, and individuals with expertise and involvement in pediatric trials will be involved throughout the project. SPIRIT-C/CONSORT-C will be disseminated through publications, academic conferences, and endorsement by pediatric journals and relevant research networks and organizations.
DISCUSSION
CONCLUSIONS
SPIRIT/CONSORT-C may serve as resources to facilitate comprehensive reporting needed to understand pediatric clinical trial protocols and reports, which may improve transparency within pediatric clinical trials and reduce research waste.
TRIAL REGISTRATION
BACKGROUND
The development of these reporting guidelines is registered with the EQUATOR Network: SPIRIT-Children ( https://www.equator-network.org/library/reporting-guidelines-under-development/reporting-guidelines-under-development-for-clinical-trials-protocols/#35 ) and CONSORT-Children ( https://www.equator-network.org/library/reporting-guidelines-under-development/reporting-guidelines-under-development-for-clinical-trials/#CHILD ).
Identifiants
pubmed: 38287439
doi: 10.1186/s13063-024-07948-7
pii: 10.1186/s13063-024-07948-7
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
96Subventions
Organisme : CIHR
ID : KRS 329021
Pays : Canada
Informations de copyright
© 2024. The Author(s).
Références
Brewster R, Wong M, Magnani CJ, Gunningham H, Hoffer M, Showalter S, et al. Early discontinuation, results reporting, and publication of pediatric clinical trials. Pediatrics. 2022;149(4)
Speer EM, Lee LK, Bourgeois FT, Gitterman D, Hay WW Jr, Davis JM, et al. The state and future of pediatric research-an introductory overview: the state and future of pediatric research series. Pediatr Res. 2023;1-5
Lagler FB, Hirschfeld S, Kindblom JM. Challenges in clinical trials for children and young people. Arch Dis Child. 2021;106(4):321–5.
pubmed: 33077422
doi: 10.1136/archdischild-2019-318676
Chan AW, Altman DG. Epidemiology and reporting of randomised trials published in PubMed journals. Lancet. 2005;365(9465):1159–62.
pubmed: 15794971
doi: 10.1016/S0140-6736(05)71879-1
Dechartres A, Trinquart L, Atal I, Moher D, Dickersin K, Boutron I, et al. Evolution of poor reporting and inadequate methods over time in 20 920 randomised controlled trials included in Cochrane reviews: research on research study. BMJ. 2017;357:j2490.
pubmed: 28596181
doi: 10.1136/bmj.j2490
Hopewell S, Dutton S, Yu LM, Chan AW, Altman DG. The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed. BMJ. 2010;340:c723.
pubmed: 20332510
pmcid: 2844941
doi: 10.1136/bmj.c723
Van Calster B, Wynants L, Riley RD, van Smeden M, Collins GS. Methodology over metrics: current scientific standards are a disservice to patients and society. J Clin Epidemiol. 2021;138:219–26.
pubmed: 34077797
pmcid: 8795888
doi: 10.1016/j.jclinepi.2021.05.018
Chalmers I, Glasziou P. Avoidable waste in the production and reporting of research evidence. Lancet. 2009;374(9683):86–9.
pubmed: 19525005
doi: 10.1016/S0140-6736(09)60329-9
Joseph PD, Caldwell PH, Barnes EH, Hynes K, Choong CS, Turner S, et al. Completeness of protocols for clinical trials in children submitted to ethics committees. J Paediatr Child Health. 2019;55(3):291–8.
pubmed: 30161286
doi: 10.1111/jpc.14189
Gates A, Hartling L, Vandermeer B, Caldwell P, Contopoulos-Ioannidis DG, Curtis S, et al. The conduct and reporting of child health research: an analysis of randomized controlled trials published in 2012 and evaluation of change over 5 years. J Pediatr. 2018;193(237-44):e37.
Hamm MP, Hartling L, Milne A, Tjosvold L, Vandermeer B, Thomson D, et al. A descriptive analysis of a representative sample of pediatric randomized controlled trials published in 2007. BMC Pediatr. 2010;10:96.
pubmed: 21176224
pmcid: 3018376
doi: 10.1186/1471-2431-10-96
Bhaloo Z, Adams D, Liu Y, Hansraj N, Hartling L, Terwee CB, et al. Primary Outcomes Reporting in Trials (PORTal): a systematic review of inadequate reporting in pediatric randomized controlled trials. J Clin Epidemiol. 2017;81:33–41.
pubmed: 27667370
doi: 10.1016/j.jclinepi.2016.09.003
Monsour A, Mew EJ, Patel S, Chee ATA, Saeed L, Santos L, et al. Primary outcome reporting in adolescent depression clinical trials needs standardization. BMC Med Res Methodol. 2020;20(1):129.
pubmed: 32450810
pmcid: 7247139
doi: 10.1186/s12874-020-01019-6
Kapadia MZ, Joachim KC, Balasingham C, Cohen E, Mahant S, Nelson K, et al. A core outcome set for children with feeding tubes and neurologic impairment: a systematic review. Pediatrics. 2016;138(1)
Yu AM, Balasubramanaiam B, Offringa M, Kelly LE. Reporting of interventions and “standard of care” control arms in pediatric clinical trials: a quantitative analysis. Pediatr Res. 2018;84(3):393–8.
pubmed: 29899384
doi: 10.1038/s41390-018-0019-7
Zaslawski Z, Balasubramanaiam B, Kelly LE. Is your standard, my standard? Why control arm reporting matters in pediatric clinical trials. Pediatr Res. 2020;88(4):544–5.
pubmed: 32428927
doi: 10.1038/s41390-020-0974-7
Brewster RCL, Steinberg JR, Magnani CJ, Jackson J, Wong BO, Valikodath N, et al. Race and ethnicity reporting and representation in pediatric clinical trials. Pediatrics. 2023;151(4)
Rees CA, Stewart AM, Portillo EN, Mehta S, Avakame E, Jackson J, et al. Reporting of important social determinants of health in pediatric clinical trials. Am J Prev Med. 2023;64(6):918–26.
pubmed: 36610922
doi: 10.1016/j.amepre.2022.12.004
Li Q, Zhou Q, Florez ID, Mathew JL, Amer YS, Estill J, et al. Reporting standards for child health research were few and poorly implemented. J Clin Epidemiol. 2023;
Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gotzsche PC, Krleza-Jeric K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200–7.
pubmed: 23295957
pmcid: 5114123
doi: 10.7326/0003-4819-158-3-201302050-00583
Schulz K, Altman D, Moher D, Group TC. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332.
pubmed: 20332509
pmcid: 2844940
doi: 10.1136/bmj.c332
Hopewell S, Boutron I, Chan AW, Collins GS, de Beyer JA, Hrobjartsson A, et al. An update to SPIRIT and CONSORT reporting guidelines to enhance transparency in randomized trials. Nat Med. 2022;28(9):1740–3.
pubmed: 36109642
doi: 10.1038/s41591-022-01989-8
Hopewell S, Chan A, Boutron I, Hrobjartsson A, Collins G, Tunn R, et al. Protocol for updating the SPIRIT 2013 (Standard Protocol Items: Recommendations for Interventional Trials) and CONSORT 2010 (CONsolidated Standards Of Reporting Trials) Statements. 2022.
Caldwell PH, Murphy SB, Butow PN, Craig JC. Clinical trials in children. Lancet. 2004;364(9436):803–11.
pubmed: 15337409
doi: 10.1016/S0140-6736(04)16942-0
Sinha IP, Altman DG, Beresford MW, Boers M, Clarke M, Craig J, et al. Standard 5: selection, measurement, and reporting of outcomes in clinical trials in children. Pediatrics. 2012;129(Suppl 3):S146–52.
pubmed: 22661761
doi: 10.1542/peds.2012-0055H
van der Tweel I, Askie L, Vandermeer B, Ellenberg S, Fernandes RM, Saloojee H, et al. Standard 4: determining adequate sample sizes. Pediatrics. 2012;129(Suppl 3):S138–45.
pubmed: 22661760
doi: 10.1542/peds.2012-0055G
Nikolakopoulos S, Roes KC, van der Lee JH, van der Tweel I. Sample size calculations in pediatric clinical trials conducted in an ICU: a systematic review. Trials. 2014;15:274.
pubmed: 25004909
pmcid: 4107993
doi: 10.1186/1745-6215-15-274
Caldwell PH, Dans L, de Vries MC, Newman Ba Hons J, Sammons H, Spriggs MBM, et al. Standard 1: consent and recruitment. Pediatrics. 2012;129(Suppl 3):S118–23.
pubmed: 22661757
doi: 10.1542/peds.2012-0055D
Leibson T, Koren G. Informed consent in pediatric research. Paediatr Drugs. 2015;17(1):5–11.
pubmed: 25420675
doi: 10.1007/s40272-014-0108-y
Gates A, Caldwell P, Curtis S, Dans L, Fernandes RM, Hartling L, et al. Consent and recruitment: the reporting of paediatric trials published in 2012. BMJ Paediatr Open. 2018;2(1):e000369.
pubmed: 30555937
pmcid: 6267313
doi: 10.1136/bmjpo-2018-000369
Ungar D, Joffe S, Kodish E. Children are not small adults: documentation of assent for research involving children. J Pediatr. 2006;149(1 Suppl):S31–3.
pubmed: 16829240
doi: 10.1016/j.jpeds.2006.04.048
Laventhal N, Tarini BA, Lantos J. Ethical issues in neonatal and pediatric clinical trials. Pediatr Clin N Am. 2012;59(5):1205–20.
doi: 10.1016/j.pcl.2012.07.007
Williams K, Thomson D, Seto I, Contopoulos-Ioannidis DG, Ioannidis JP, Curtis S, et al. Standard 6: age groups for pediatric trials. Pediatrics. 2012;129(Suppl 3):S153–60.
pubmed: 22661762
doi: 10.1542/peds.2012-0055I
Vanderhout SM, Bhalla M, Van A, Fergusson DA, Potter BK, Karoly A, et al. The impact of patient and family engagement in child health research: a scoping review. J Pediatr. 2023;253:115–28.
pubmed: 36179891
doi: 10.1016/j.jpeds.2022.09.030
Molloy EJ, Mader S, Modi N, Gale C. Parent, child and public involvement in child health research: core value not just an optional extra. Pediatr Res. 2019;85(1):2–3.
pubmed: 30531982
doi: 10.1038/s41390-018-0245-z
Leonard MB, Pursley DM, Robinson LA, Abman SH, Davis JM. The importance of trustworthiness: lessons from the COVID-19 pandemic. Pediatr Res. 2022;91(3):482–5.
pubmed: 34853429
doi: 10.1038/s41390-021-01866-z
Baba A, Offringa M. Transparent reporting-SPIRIT-C/CONSORT-C pediatric updates. JAMA Pediatr; 2023.
doi: 10.1001/jamapediatrics.2023.5740
Moher D, Schulz KF, Simera I, Altman DG. Guidance for developers of health research reporting guidelines. PLoS Med. 2010;7(2):e1000217.
pubmed: 20169112
pmcid: 2821895
doi: 10.1371/journal.pmed.1000217
Boutron I, Altman DG, Moher D, Schulz KF, Ravaud P, Group CN. CONSORT statement for randomized trials of nonpharmacologic treatments: a 2017 update and a CONSORT extension for nonpharmacologic trial abstracts. Ann Intern Med. 2017;167(1):40–7.
pubmed: 28630973
doi: 10.7326/M17-0046
Campbell MK, Piaggio G, Elbourne DR, Altman DG, Group C. Consort 2010 statement: extension to cluster randomised trials. BMJ. 2012;345:e5661.
pubmed: 22951546
doi: 10.1136/bmj.e5661
Korevaar DA, Cohen JF, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, et al. Updating standards for reporting diagnostic accuracy: the development of STARD 2015. Res Integr Peer Rev. 2016;1:7.
pubmed: 29451535
pmcid: 5803584
doi: 10.1186/s41073-016-0014-7
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement. J Clin Epidemiol. 2021;
Piaggio G, Elbourne DR, Pocock SJ, Evans SJ, Altman DG, Group C. Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. JAMA. 2012;308(24):2594–604.
pubmed: 23268518
doi: 10.1001/jama.2012.87802
Schlussel MM, Sharp MK, de Beyer JA, Kirtley S, Logullo P, Dhiman P, et al. Reporting guidelines used varying methodology to develop recommendations. J Clin Epidemiol. 2023;
Butcher NJ, Monsour A, Mew EJ, Chan AW, Moher D, Mayo-Wilson E, et al. Guidelines for reporting outcomes in trial protocols: the SPIRIT-outcomes 2022 extension. JAMA. 2022;328(23):2345–56.
pubmed: 36512367
doi: 10.1001/jama.2022.21243
Butcher NJ, Monsour A, Mew EJ, Chan AW, Moher D, Mayo-Wilson E, et al. Guidelines for reporting outcomes in trial reports: the CONSORT-outcomes 2022 extension. JAMA. 2022;328(22):2252–64.
pubmed: 36511921
doi: 10.1001/jama.2022.21022
Elsman EBM, Butcher NJ, Mokkink LB, Terwee CB, Tricco A, Gagnier JJ, et al. Study protocol for developing, piloting and disseminating the PRISMA-COSMIN guideline: a new reporting guideline for systematic reviews of outcome measurement instruments. Syst Rev. 2022;11(1):121.
pubmed: 35698213
pmcid: 9195229
doi: 10.1186/s13643-022-01994-5
CONSORT Extension for trials in Child Health: CONSORT-C EQUATOR Network [Available from: https://www.equator-network.org/library/reporting-guidelines-under-development/reporting-guidelines-under-development-for-clinical-trials/#CHILD .
SPIRIT Extension for trials in Child Health: SPIRIT-C EQUATOR Network [Available from: https://www.equator-network.org/library/reporting-guidelines-under-development/reporting-guidelines-under-development-for-clinical-trials-protocols/#35 .
Guidelines for reporting in pediatric clinical trial protocols and reports: SPIRIT-Children (SPIRIT-C) and CONSORT-Children (CONSORT-C) - Open Science Framework Files [Available from: https://osf.io/bka4e/ .
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research Electronic Data Capture (REDCap) - a meta data-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–81.
pubmed: 18929686
doi: 10.1016/j.jbi.2008.08.010
World Health Organization. Adolescent health in the South-East Asia Region. Geneva: World Health Organization; 2022.
Schoemaker CG, Richards DP, de Wit M. Matching researchers’ needs and patients’ contributions: practical tips for meaningful patient engagement from the field of rheumatology. Ann Rheum Dis. 2023;82(3):312–5.
pubmed: 36604151
doi: 10.1136/ard-2022-223561
SPOR Networks in Chronic Diseases and the PICHI Network. Recommendations on Patient Engagement Compensation 2018 [Available from: https://diabetesaction.ca/wp-content/uploads/2018/07/TASK-FORCE-IN-PATIENT-ENGAGEMENT-COMPENSATION-REPORT_FINAL-1.pdf . .
Manafo E, Petermann L, Mason-Lai P, Vandall-Walker V. Patient engagement in Canada: a scoping review of the ‘how’and ‘what’of patient engagement in health research. Health research policy and systems. 2018;16(1):1–11.
Public Involvement Impact Assessment Framework (PiiAF) [6 June 2023]. Available from: https://piiaf.org.uk/ .
Abelson J, Li K, Wilson G, Shields K, Schneider C, Boesveld S. Supporting quality public and patient engagement in health system organizations: development and usability testing of the Public and Patient Engagement Evaluation Tool. Health Expect. 2016;19(4):817–27.
pubmed: 26113295
doi: 10.1111/hex.12378
Hamilton CB, Hoens AM, McQuitty S, McKinnon AM, English K, Backman CL, et al. Development and pre-testing of the Patient Engagement In Research Scale (PEIRS) to assess the quality of engagement from a patient perspective. PLoS One. 2018;13(11):e0206588.
pubmed: 30383823
pmcid: 6211727
doi: 10.1371/journal.pone.0206588
Clyburne-Sherin AV, Thurairajah P, Kapadia MZ, Sampson M, Chan WW, Offringa M. Recommendations and evidence for reporting items in pediatric clinical trial protocols and reports: two systematic reviews. Trials. 2015;16:417.
pubmed: 26385379
pmcid: 4574457
doi: 10.1186/s13063-015-0954-0
Butcher NJ, et al. Plain Language Result Summary for Pediatric Clinical Trials: CommuniKIDS: Clinical Trials Ontario; [Available from: https://www.ctontario.ca/patients-public/resources-for-engaging-patients/toolkit-to-improve-clinical-trial-participants-experiences/plain-language-result-summary-for-pediatric-clinical-trials/#tab11 .
Powell C. The Delphi technique: myths and realities. J Adv Nurs. 2003;41(4):376–82.
pubmed: 12581103
doi: 10.1046/j.1365-2648.2003.02537.x
de Villiers MR, de Villiers PJ, Kent AP. The Delphi technique in health sciences education research. Med Teach. 2005;27(7):639–43.
pubmed: 16332558
doi: 10.1080/13611260500069947
Diamond IR, Grant RC, Feldman BM, Pencharz PB, Ling SC, Moore AM, et al. Defining consensus: a systematic review recommends methodologic criteria for reporting of Delphi studies. J Clin Epidemiol. 2014;67(4):401–9.
pubmed: 24581294
doi: 10.1016/j.jclinepi.2013.12.002
Williamson PR, Altman DG, Bagley H, Barnes KL, Blazeby JM, Brookes ST, et al. The COMET Handbook: Version 1.0. Trials. 2017;18(Suppl 3):280.
pubmed: 28681707
pmcid: 5499094
doi: 10.1186/s13063-017-1978-4
Wylde V, MacKichan F, Bruce J, Gooberman-Hill R. Assessment of chronic post-surgical pain after knee replacement: development of a core outcome set. Eur J Pain. 2015;19(5):611–20.
pubmed: 25154614
doi: 10.1002/ejp.582
Calvert M, Kyte D, Mercieca-Bebber R, Slade A, Chan AW, King MT, et al. Guidelines for inclusion of patient-reported outcomes in clinical trial protocols: The SPIRIT-PRO Extension. JAMA. 2018;319(5):483–94.
pubmed: 29411037
doi: 10.1001/jama.2017.21903
Kirkham JJ, Gorst S, Altman DG, Blazeby JM, Clarke M, Devane D, et al. Core outcome set-STAndards for reporting: the COS-STAR statement. PLoS Med. 2016;13(10):e1002148.
pubmed: 27755541
pmcid: 5068732
doi: 10.1371/journal.pmed.1002148
Webbe J, Allin B, Knight M, Modi N, Gale C. How to reach agreement: the impact of different analytical approaches to Delphi process results in core outcomes set development. Trials. 2023;24(1):345.
pubmed: 37217933
pmcid: 10201748
doi: 10.1186/s13063-023-07285-1
Williamson PR, Altman DG, Blazeby JM, Clarke M, Devane D, Gargon E, et al. Developing core outcome sets for clinical trials: issues to consider. Trials. 2012;13(1):132.
pubmed: 22867278
pmcid: 3472231
doi: 10.1186/1745-6215-13-132
Collins GS, Dhiman P, Andaur Navarro CL, Ma J, Hooft L, Reitsma JB, et al. Protocol for development of a reporting guideline (TRIPOD-AI) and risk of bias tool (PROBAST-AI) for diagnostic and prognostic prediction model studies based on artificial intelligence. BMJ Open. 2021;11(7):e048008.
pubmed: 34244270
pmcid: 8273461
doi: 10.1136/bmjopen-2020-048008
Grant S, Mayo-Wilson E, Montgomery P, Macdonald G, Michie S, Hopewell S, et al. CONSORT-SPI 2018 Explanation and Elaboration: guidance for reporting social and psychological intervention trials. Trials. 2018;19(1):406.
pubmed: 30060763
pmcid: 6066913
doi: 10.1186/s13063-018-2735-z
Defining the Role of Authors and Contributors: International Committee of Medical Journal Editors; [Available from: https://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html .
Turner L, Shamseer L, Altman DG, Schulz KF, Moher D. Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review Syst Rev. 2012;1:60.
pubmed: 23194585
doi: 10.1186/2046-4053-1-60
Samaan Z, Mbuagbaw L, Kosa D, Borg Debono V, Dillenburg R, Zhang S, et al. A systematic scoping review of adherence to reporting guidelines in health care literature. J Multidiscip Healthc. 2013;6:169–88.
pubmed: 23671390
pmcid: 3649856
Jin Y, Sanger N, Shams I, Luo C, Shahid H, Li G, et al. Does the medical literature remain inadequately described despite having reporting guidelines for 21 years? - a systematic review of reviews: an update. J Multidiscip Healthc. 2018;11:495–510.
pubmed: 30310289
pmcid: 6166749
doi: 10.2147/JMDH.S155103
Stevens A, Shamseer L, Weinstein E, Yazdi F, Turner L, Thielman J, et al. Relation of completeness of reporting of health research to journals’ endorsement of reporting guidelines: systematic review. The BMJ. 2014;348:g3804.
pubmed: 24965222
pmcid: 4070413
doi: 10.1136/bmj.g3804
Speich B, Odutayo A, Peckham N, Ooms A, Stokes JR, Saccilotto R, et al. A longitudinal assessment of trial protocols approved by research ethics committees: the Adherance to SPIrit REcommendations in the UK (ASPIRE-UK) study. Trials. 2022;23(1):601.
pubmed: 35897110
pmcid: 9327179
doi: 10.1186/s13063-022-06516-1
Siebert M, Naudet F, Ioannidis JPA. Peer review before trial conduct could increase research value and reduce waste. J Clin Epidemiol. 2023;
Howick J, Webster R, Knottnerus JA, Moher D. Do overly complex reporting guidelines remove the focus from good clinical trials? BMJ. 2021;374:n1793.
pubmed: 34400403
doi: 10.1136/bmj.n1793
Burke NN, Stewart D, Tierney T, Worrall A, Smith M, Elliott J, et al. Sharing space at the research table: exploring public and patient involvement in a methodology priority setting partnership. Res Involv Engagem. 2023;9(1):29.
pubmed: 37131232
pmcid: 10152423
doi: 10.1186/s40900-023-00438-1